FDA review clears path for second coronavirus vaccine, this one developed by Moderna
The vaccine appears poised for regulatory clearance after a detailed data review by Food and Drug Administration scientists confirmed the two-shot regimen was “highly effective” in a clinical trial and carried no serious safety concerns.